The performance of companies tied to Sildenafil's past presents a challenging investment scenario . While the initial surge generated substantial profits , generic alternatives have significantly impacted revenue. Investing in associated pharmaceutical businesses now requires a careful assessment of patent safeguards, evolving healthcare shifts … Read More